Anticoagulant management of atrial fibrillation: the influence of dosing algorithm and recall schedule on time in therapeutic range

被引:1
|
作者
Nantha, Y. Swarna [1 ,2 ]
机构
[1] Seremban Primary Care Clin, Primary Care Res Initiat, Seremban 70300, Negeri Sembilan, Malaysia
[2] Seremban Primary Care Clin, Methods Educ Dept PRIMED, Seremban 70300, Negeri Sembilan, Malaysia
关键词
Atrial fibrillation; dose nomogram; predictors; primary care; TTR; warfarin; INTERNATIONAL NORMALIZED RATIO; PRIMARY-CARE; WARFARIN;
D O I
10.1093/fampra/cmv066
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The quality of anticoagulation management in atrial fibrillation patients is reflected by the concept of time spent in therapeutic range (TTR). In a primary care setting, the implementation of a dose nomogram could help increase the mean TTR among these patients. Objective. This study compares the influence of a dose algorithm with an integrated recall on TTR prior to standard care and after the implementation of the protocol. Patients and methods. In a purposive sample of patients with AF, an uncontrolled 'before' and 'after' study design was utilized to measure the effects of the protocol on TTR. Demographic data, TTR levels, frequency of international normalized ratio (INR) within therapeutic range, clinician adherence to dose nomogram and warfarin dose changes were captured from consultations at the anticoagulation clinic. Results. A total of 152 patients with AF were entered into the final analysis. The increment in mean TTR in the 'after' intervention phase (2.9%) was not statistically significant (57.5-60.4%, P = 0.252). The increase in the frequency of INR values within therapeutic range in the 'after' intervention phase was significant (50.0-56.0%, P < 0.05) but with a very low effect size (r = 0.04). Conclusions. The implementation of a dose nomogram has the potential of reducing unnecessary dose changes for minor fluctuations in INR levels. The findings in this study needs to be confirmed in a future study involving other indications for anticoagulation, various regional primary care clinics and a larger population size.
引用
收藏
页码:514 / 519
页数:6
相关论文
共 50 条
  • [41] Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service
    Phelps, Elise
    Delate, Thomas
    Witt, Daniel M.
    Shaw, Paul B.
    McCool, Kathleen H.
    Clark, Nathan P.
    THROMBOSIS RESEARCH, 2018, 163 : 54 - 59
  • [42] Time in Therapeutic Range Using a Nomogram for Dose Adjustment of Warfarin in Patients on Hemodialysis With Atrial Fibrillation
    Defoe, Kimberly
    Wichart, Jenny
    Leung, Kelvin
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [43] Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation
    Liu, Shuqian
    Li, Xiaoyan
    Shi, Qian
    Hamilton, Melissa
    Friend, Keith
    Zhao, Yingnan
    Horblyuk, Ruslan
    Hede, Shalini
    Shi, Lizheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (03) : 415 - 421
  • [44] Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients
    Bruria Hirsh Raccah
    Amihai Rottenstreich
    Netanel Zacks
    Ilan Matok
    Haim D. Danenberg
    Arthur Pollak
    Yosef Kalish
    Journal of Thrombosis and Thrombolysis, 2019, 47 : 550 - 557
  • [45] Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand
    Pongsathabordee, Chayanat
    Saringkarn, Piyachat
    Ratanapornsompong, Kanjana
    Rungruang, Ratiya
    Srithonrat, Saranporn
    Tangkaotong, Pimlada
    Sena, Salintip
    Paiboonvong, Taniya
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2024, 16
  • [46] Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
    Gustafson, Whitney L.
    Saunders, John
    Vazquez, Sara R.
    Jones, Aubrey E.
    Witt, Daniel M.
    PHARMACY PRACTICE-GRANADA, 2019, 17 (04):
  • [47] Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients
    Raccah, Bruria Hirsh
    Rottenstreich, Amihai
    Zacks, Netanel
    Matok, Ilan
    Danenberg, Haim D.
    Pollak, Arthur
    Kalish, Yosef
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 550 - 557
  • [48] Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
    Douketis, James D.
    Spyropoulos, Alex C.
    Duncan, Joanne
    Carrier, Marc
    Le Gal, Gregoire
    Tafur, Alfonso J.
    Vanassche, Thomas
    Verhamme, Peter
    Shivakumar, Sudeep
    Gross, Peter L.
    Lee, Agnes Y. Y.
    Yeo, Erik
    Solymoss, Susan
    Kassis, Jeannine
    Le Templier, Genevieve
    Kowalski, Stephen
    Blostein, Mark
    Shah, Vinay
    MacKay, Elizabeth
    Wu, Cynthia
    Clark, Nathan P.
    Bates, Shannon M.
    Spencer, Frederick A.
    Arnaoutoglou, Eleni
    Coppens, Michiel
    Arnold, Donald M.
    Caprini, Joseph A.
    Li, Na
    Moffat, Karen A.
    Syed, Summer
    Schulman, Sam
    JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1469 - 1478
  • [49] Oral anticoagulant therapy management after successful atrial fibrillation ablation
    Gallo, C.
    Battaglia, A.
    Sardi, D.
    Toso, E.
    Castagno, D.
    Scaglione, M.
    Gaita, F.
    EUROPEAN HEART JOURNAL, 2013, 34 : 99 - 100
  • [50] Diltiazem Dosing Strategies in the Management of Atrial Fibrillation With Rapid Ventricular Rate
    Bishop, James, Jr.
    Akram, Ghufraan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)